Literature DB >> 21660944

The p53 tumor suppressor protein regulates hematopoietic stem cell fate.

Takashi Asai1, Yan Liu, Narae Bae, Stephen D Nimer.   

Abstract

The p53 tumor suppressor protein is a key transcription factor that regulates several signaling pathways involved in the cell's response to stress. Through stress-induced activation, p53 accumulates and triggers the expression of target genes that protect the genetic integrity of all cells including hematopoietic stem cells (HSCs). These protective mechanisms include cell-cycle arrest, DNA repair, induction of apoptosis, or initiation of senescence. In addition to its function under stress conditions, p53 has important functions during steady-state hematopoiesis, regulating HSC quiescence and self-renewal. In addition, it appears that p53 levels affect HSC competition for the hematopoietic niche, with the less p53 activated HSCs preferentially surviving. The specific genes and precise mechanisms underlying p53's effects on normal HSCs are slowly being clarified. p53 also plays an important role in leukemia stem cell (LSC) behavior, with p53 loss affecting drug resistance and disease progression. Pharmacologic activation of p53 function could overcome the adverse impact of p53 inactivation in LSCs. Thus, understanding the p53 regulatory mechanisms active in HSCs and LSCs may promote the development of new therapeutic strategies that could eliminate the population of largely quiescent LSCs.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21660944      PMCID: PMC3081536          DOI: 10.1002/jcp.22561

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  156 in total

1.  p53 suppresses the self-renewal of adult neural stem cells.

Authors:  Konstantinos Meletis; Valtteri Wirta; Sanna-Maria Hede; Monica Nistér; Joakim Lundeberg; Jonas Frisén
Journal:  Development       Date:  2006-01       Impact factor: 6.868

2.  Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia.

Authors:  H Ahuja; M Bar-Eli; S H Advani; S Benchimol; M J Cline
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

3.  Mutations of the P53 gene in acute myeloid leukaemia.

Authors:  P Fenaux; C Preudhomme; I Quiquandon; P Jonveaux; J L Laï; M Vanrumbeke; M H Loucheux-Lefebvre; F Bauters; R Berger; J P Kerckaert
Journal:  Br J Haematol       Date:  1992-02       Impact factor: 6.998

4.  p53 mutant mice that display early ageing-associated phenotypes.

Authors:  Stuart D Tyner; Sundaresan Venkatachalam; Jene Choi; Stephen Jones; Nader Ghebranious; Herbert Igelmann; Xiongbin Lu; Gabrielle Soron; Benjamin Cooper; Cory Brayton; Sang Hee Park; Timothy Thompson; Gerard Karsenty; Allan Bradley; Lawrence A Donehower
Journal:  Nature       Date:  2002-01-03       Impact factor: 49.962

5.  Suppression of induced pluripotent stem cell generation by the p53-p21 pathway.

Authors:  Hyenjong Hong; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Osami Kanagawa; Masato Nakagawa; Keisuke Okita; Shinya Yamanaka
Journal:  Nature       Date:  2009-08-09       Impact factor: 49.962

6.  Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53.

Authors:  W E Mercer; M T Shields; M Amin; G J Sauve; E Appella; J W Romano; S J Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

7.  Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53.

Authors:  S N Jones; A E Roe; L A Donehower; A Bradley
Journal:  Nature       Date:  1995-11-09       Impact factor: 49.962

8.  Enrichment of hematopoietic stem cells with SLAM and LSK markers for the detection of hematopoietic stem cell function in normal and Trp53 null mice.

Authors:  Jichun Chen; Felicia M Ellison; Keyvan Keyvanfar; Stephanie O Omokaro; Marie J Desierto; Michael A Eckhaus; Neal S Young
Journal:  Exp Hematol       Date:  2008-06-17       Impact factor: 3.084

Review 9.  Pharmacological activation of the p53 pathway in haematological malignancies.

Authors:  Manujendra N Saha; Johann Micallef; Lugui Qiu; Hong Chang
Journal:  J Clin Pathol       Date:  2009-12-02       Impact factor: 3.411

Review 10.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

View more
  39 in total

Review 1.  Control dominating subclones for managing cancer progression and posttreatment recurrence by subclonal switchboard signal: implication for new therapies.

Authors:  Shengwen Calvin Li; Katherine L Lee; Jane Luo
Journal:  Stem Cells Dev       Date:  2011-11-02       Impact factor: 3.272

2.  Necdin, a p53 target gene, regulates the quiescence and response to genotoxic stress of hematopoietic stem/progenitor cells.

Authors:  Takashi Asai; Yan Liu; Silvana Di Giandomenico; Narae Bae; Delphine Ndiaye-Lobry; Anthony Deblasio; Silvia Menendez; Yevgeniy Antipin; Boris Reva; Rachel Wevrick; Stephen D Nimer
Journal:  Blood       Date:  2012-07-09       Impact factor: 22.113

3.  HDAC8 regulates long-term hematopoietic stem-cell maintenance under stress by modulating p53 activity.

Authors:  Wei-Kai Hua; Jing Qi; Qi Cai; Emily Carnahan; Maria Ayala Ramirez; Ling Li; Guido Marcucci; Ya-Huei Kuo
Journal:  Blood       Date:  2017-10-30       Impact factor: 22.113

Review 4.  Surviving change: the metabolic journey of hematopoietic stem cells.

Authors:  Latika Kohli; Emmanuelle Passegué
Journal:  Trends Cell Biol       Date:  2014-04-24       Impact factor: 20.808

5.  Caspase-9 is required for normal hematopoietic development and protection from alkylator-induced DNA damage in mice.

Authors:  Elise Peterson Lu; Michael McLellan; Li Ding; Robert Fulton; Elaine R Mardis; Richard K Wilson; Christopher A Miller; Peter Westervelt; John F DiPersio; Daniel C Link; Matthew J Walter; Timothy J Ley; Timothy A Graubert
Journal:  Blood       Date:  2014-10-27       Impact factor: 22.113

6.  Prdm16 is a physiologic regulator of hematopoietic stem cells.

Authors:  Francesca Aguilo; Serine Avagyan; Amy Labar; Ana Sevilla; Dung-Fang Lee; Parameet Kumar; Ihor R Lemischka; Betty Y Zhou; Hans-Willem Snoeck
Journal:  Blood       Date:  2011-02-22       Impact factor: 22.113

Review 7.  AMP-activated protein kinase, stress responses and cardiovascular diseases.

Authors:  Shaobin Wang; Ping Song; Ming-Hui Zou
Journal:  Clin Sci (Lond)       Date:  2012-06       Impact factor: 6.124

Review 8.  DNA damage response, redox status and hematopoiesis.

Authors:  Cary N Weiss; Keisuke Ito
Journal:  Blood Cells Mol Dis       Date:  2013-09-13       Impact factor: 3.039

Review 9.  Control of stress signaling in stem cells: crossroads of stem cells and cancer.

Authors:  Seung-Ju Cho; JaeHyung Koo; Kwang-Hoon Chun; Hyuk-Jin Cha
Journal:  Tumour Biol       Date:  2016-07-27

Review 10.  Stem cell competition: finding balance in the niche.

Authors:  Rachel R Stine; Erika L Matunis
Journal:  Trends Cell Biol       Date:  2013-04-16       Impact factor: 20.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.